
Chemotherapy treatments and other conditions such as Turner's and galactosemia can threaten the future fertility of children.
At IFP, we offer innovative gamete and tissue freezing procedures to all ages of male and female children.
While mature men can preserve fertility by sperm freezing, the only option in male children is testicular tissue freezing.
At IFP, we offer this experimental option for children undergoing chemotherapy.
Eggs are harvested for safekeeping in advance of cancer treatments, and reimplanted in an IVF procedure when the patient's cancer is in remission.
We developed innovative strategies to keep estrogen levels low during ovarian stimulation to collect eggs so that cancer recurrence is not increased.
Oocyte freezing has come a long way. Our research shows that current success rates have approached to that of standard IVF procedures.
When fertility is under threat in single women and adolescents, this is a useful strategy to preserve fertility.
This technique does not require ovarian stimulation and can be performed in children and adults with short notice.
IFP's experience is unmatched, as Dr Oktay performed the first procedures in the world.
Kutluk Oktay, MD, FACOG is one of the world's foremost experts in fertility preservation as well as ovarian stimulation and in vitro fertilization for infertility treatments. He developed and performed the world's first ovarian transplantation procedures as well as pioneered new ovarian stimulation protocols for embryo and oocyte freezing for breast and endometrial cancer patients. Dr. Oktay conducted key research on ovarian follicle and embryo development, as well as on controlled ovarian stimulation and in vitro fertilization.
Dr. Oktay has devoted his professional life to the science of fertility preservation and infertility treatment. He is a world-renowned researcher, a gifted medical educator, and a skilled clinician dedicated to his patients. Dr. Oktay was invited to the President's Cancer Panel as an expert on fertility issues of cancer patients and fertility preservation. In attestation to his recognition as a leading clinician-scientist in infertility field, he received a highly competitive multi- million-dollar research grant from the National Institute of Health to study the impact of chemotherapy on fertility of cancer survivors. Furthermore, he was named the co-chair of the American Society of Clinical Oncology Committee for Fertility Preservation Guideline for People with Cancer. He founded and was elected as the first President of the Fertility Preservation Special Interest Group at American Society of Reproductive Medicine.
In 2008, after a 10-year career at the Weill Medical College of Cornell University, Dr. Oktay became a Professor of Obstetrics & Gynecology and the Director of Division of Reproductive Medicine & Infertility at New York Medical College/Westchester Medical Center and founded the Center for Reproductive Medicine and Institute for Fertility Preservation (CRM-IFP). He also was named a Consultant Physician at Memorial Sloan-Kettering Cancer Center, and a Consultant for Cancer and Allied Diseases at Memorial Hospital.
Dr. Oktay has published extensively in top medical journals, such as the New England Journal of Medicine, Lancet, JAMA, and Journal of Clinical Oncology. He regularly lectures around the globe and has repeatedly received the Top Doctors awards around the country. Dr. Oktay's research has made news around the globe. View Dr. Kutluk Oktay's current curriculum vitae.